KR101328179B1 - Preparation method of fermented red ginseng having high ginsenoside contents using surface culture - Google Patents
Preparation method of fermented red ginseng having high ginsenoside contents using surface culture Download PDFInfo
- Publication number
- KR101328179B1 KR101328179B1 KR1020110083090A KR20110083090A KR101328179B1 KR 101328179 B1 KR101328179 B1 KR 101328179B1 KR 1020110083090 A KR1020110083090 A KR 1020110083090A KR 20110083090 A KR20110083090 A KR 20110083090A KR 101328179 B1 KR101328179 B1 KR 101328179B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- red ginseng
- fermented
- fermentation
- content
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 78
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 21
- 229940089161 ginsenoside Drugs 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title description 4
- 241000208340 Araliaceae Species 0.000 claims abstract description 90
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 90
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 90
- 235000008434 ginseng Nutrition 0.000 claims abstract description 90
- 240000001929 Lactobacillus brevis Species 0.000 claims abstract description 15
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 12
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000012136 culture method Methods 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 description 40
- 230000004151 fermentation Effects 0.000 description 40
- 230000000052 comparative effect Effects 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 235000017709 saponins Nutrition 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000007640 basal medium Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003017 phosphorus Chemical class 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Abstract
본 발명은 락토바실러스 브레비스 M2(Lactobacillus brevis) M2(기탁번호 KCTC11390BP)로 표면을 발효시킨 인삼을 이용하여 진세노사이드 함량이 높은 홍삼을 제조하는 방법에 대한 것이다. The present invention relates to a method for producing red ginseng having a high ginsenoside content using ginseng fermented with Lactobacillus brevis M2 (Accession No. KCTC11390BP).
Description
본 발명은 인삼의 표면을 발효시키고, 상기 표면 발효 인삼을 이용하여 발효 홍삼을 제조하는 방법에 대한 것이다.
The present invention relates to a method of fermenting the surface of ginseng and manufacturing fermented red ginseng using the surface fermented ginseng.
홍삼은 수삼을 세척, 증자, 1차 건조(수분함량 35-40%), 저장 숙성, 2차 건조(수분함량 16% 내외), 정형 등의 과정을 거쳐 제조되며, 담황갈색 또는 담적갈색을 띤다. 홍삼의 제조 공정 과정에서 수삼을 증자 열처리하면 성분의 화학적 변화가 일어나 수삼이나 백삼에 존재하지 않는 새로운 생리활성물질의 생성과 함께 기존의 생리활성물질 함량이 증가한다. 홍삼 제조 과정 동안 변화되는 주요한 성분은 사포닌계와 비사포닌계로서 사포닌계 성분을 보면 홍삼에 30종 백삼에는 22종이 분리되어 보고되어 있으며, 홍삼과 백삼에 공통함유 18종, 홍삼에 특이적으로 존재하는 사포닌 12종, 백삼에만 존재하는 4종의 사포닌이 규명되어 있다.
Red ginseng is prepared by washing, increasing steaming, steaming, primary drying (water content of 35-40%), storage aging, secondary drying (about 16% water content), and shaping, and are pale yellow or light brown. . When heat-treatment of red ginseng during the manufacturing process of red ginseng causes chemical changes of ingredients, the content of existing bioactive substances increases with the generation of new bioactive substances that do not exist in fresh ginseng or white ginseng. The major components that change during the manufacturing process of red ginseng are saponin-based and non-saponin-based. According to the saponin-based components, 22 kinds of white ginseng and 22 kinds of red ginseng have been reported separately. 12 kinds of saponins, four kinds of saponins that exist only in white ginseng have been identified.
인삼의 사포닌은 항암 작용, 항산화 작용, 동맥경화 및 고혈압 예방, 간기능개선, 항피로, 항스트레스 작용, 노화방지, 두뇌활동 촉진, 항염활성, 알레르기성 질환치료 및 단백질합성 능력의 촉진 등의 생리활성이 있으며, 고려 홍삼은 항산화, 혈압강하, 알코올성 고지혈증 개선, 혈당강하작용 등의 우수한 생리활성을 지니고 있다.
Saponins of ginseng have physiological effects such as anticancer activity, antioxidant activity, arteriosclerosis and hypertension prevention, liver function improvement, antifatigue, antistress action, anti-aging, brain activity promotion, anti-inflammatory activity, allergic disease treatment and protein synthesis ability. Korean red ginseng has excellent physiological activities such as antioxidant, lowering blood pressure, improving alcoholic hyperlipidemia and lowering blood sugar.
홍삼의 다양하고 우수한 약리활성 작용에도 불구하고 개인별 장내 미생물의 분포 및 활성화의 차이로 인하여 실제로 홍삼의 약효에 차이에 나타낼 수 있다. 이를 극복하기 위하여 홍삼을 장내 미생물을 이용하여 발효(fermentation)하는 과정을 거쳐 최종 대사산물의 성분으로 변환 혹은 증가시키는 발효홍삼 제조에 관한 연구 및 개발이 이루어지고 있다.
In spite of the diverse and excellent pharmacological activity of red ginseng, the difference in the distribution and activation of individual intestinal microorganisms may actually indicate the difference in the efficacy of red ginseng. In order to overcome this problem, research and development on fermented red ginseng that convert or increase red ginseng into the components of the final metabolite after fermentation (fermentation) using intestinal microorganisms have been conducted.
예컨대, 한국공개특허 10-2010-0079874는 홍삼에 유산균을 배양하여 발효시킨 발효 홍삼을 제공하고, 한국공개특허 10-2010-0074382는 인삼 분말에 유산균을 접종하여 발효시킨 인삼 발효물을 제공하며, 한국등록특허 10-0866504에는 홍삼 분말에 락토바실러스 브레비스를 접종하여 발효시킨 발효홍삼이 기재되어 있다.
For example, Korean Patent Laid-Open No. 10-2010-0079874 provides fermented red ginseng fermented by culturing lactic acid bacteria in red ginseng, and Korean Laid-open Patent No. 10-2010-0074382 provides a ginseng fermented product inoculated with fermented lactic acid bacteria in ginseng powder. Korean Patent No. 10-0866504 describes fermented red ginseng fermented by inoculating Lactobacillus brevis into red ginseng powder.
그러나 상기 기술들은 균주를 인삼 또는 홍삼에 심부배양하여 발효시킨 것이며, 표면배양(고체배양)으로 발효시킨 것이 아니었다. 본 발명자들은 발효 홍삼의 제조 방법에 대하여 연구를 계속하던 중, 락토바실러스 브레비스 M2(Lactobacillus brevis) M2(기탁번호 KCTC11390BP)로 인삼의 표면을 배양시켜 표면 발효 인삼 제조하고, 이를 이용하여 홍삼을 제조할 경우, 상기 발효 홍삼의 진세노사이드 함량이 유의미하게 증가하는 것을 발견하고 본 발명을 완성하였다.
However, the techniques were fermented by deep culture in strains ginseng or red ginseng, not by surface culture (solid culture). The present inventors continue the study on the method of manufacturing fermented red ginseng, by culturing the surface of ginseng with Lactobacillus brevis M2 (Accession No. KCTC11390BP) to prepare a surface fermented ginseng, using the same to prepare red ginseng In this case, it was found that the ginsenoside content of the fermented red ginseng significantly increased and completed the present invention.
본 발명의 목적은 진세노사이드 함량이 높은 홍삼의 제조 방법을 제공하는 것이다.
An object of the present invention is to provide a method for producing red ginseng with a high ginsenoside content.
상기 목적을 달성하기 위하여 본 발명은 인삼의 표면을 발효시키고, 상기 표면 발효 인삼을 이용하여 발효 홍삼을 제조하는 방법을 제공한다.
In order to achieve the above object, the present invention provides a method of fermenting the surface of ginseng and producing fermented red ginseng using the surface fermented ginseng.
본 발명의 방법으로 제조된 발효 홍삼은 일반 홍삼에 비하여 진세노사이드 함량이 높은 특징이 있다.
Fermented red ginseng prepared by the method of the present invention is characterized by a high content of ginsenosides compared to general red ginseng.
도 1은 표면을 발효시킨 홍삼 본삼(좌측) 및 미삼(우측)이다.
도 2는 뿌리 본삼의 표면 발효중의 성분 변화를 나타낸다.
도 3은 뿌리 미삼의 표면 발효중의 성분 변화를 나타낸다.1 is red ginseng main ginseng (left) and misam (right) fermented surface.
Figure 2 shows the component changes during the surface fermentation of root main ginseng.
Figure 3 shows the changes of the components during the surface fermentation of root rice ginseng.
본 발명은,According to the present invention,
인삼을 준비하는 단계;Preparing ginseng;
상기 인삼에 락토바실러스 브레비스 M2(Lactobacillus brevis) M2(기탁번호 KCTC11390BP)를 접종하여, 상기 인삼의 표면에서 배양시키는 단계;및Inoculating the ginseng Lactobacillus brevis M2 ( Lactobacillus brevis ) M2 (Accession No. KCTC11390BP), and incubating on the surface of the ginseng; And
상기 표면배양된 인삼을 증삼하여 홍삼으로 제조하는 단계를 포함하는 발효 홍삼의 제조 방법에 대한 것이다.
It relates to a method for producing fermented red ginseng comprising the step of producing red ginseng by increasing the surface cultured ginseng.
또한 본 발명은,Further, according to the present invention,
인삼을 준비하는 단계;및Preparing ginseng; and
상기 인삼에 락토바실러스 브레비스 M2(Lactobacillus brevis) M2(기탁번호 KCTC11390BP)를 접종하여, 상기 인삼의 표면에서 배양시키는 단계를 포함하는 발효 인삼의 제조 방법에 대한 것이다.
Inoculating the ginseng Lactobacillus brevis M2 ( Lactobacillus brevis ) M2 (Accession No. KCTC11390BP), and the method for producing a fermented ginseng comprising the step of culturing on the surface of the ginseng.
또한 본 발명은 상기 방법으로 제조된 발효 홍삼 또는 발효 인삼에 대한 것이다.
The present invention also relates to fermented red ginseng or fermented ginseng prepared by the above method.
또한 본 발명은 본 발명의 발효 홍삼 또는 발효 인삼을 유효성분으로 포함하는 식품 조성물에 대한 것이다.
The present invention also relates to a food composition comprising the fermented red ginseng or fermented ginseng of the present invention as an active ingredient.
이하, 본 발명을 자세히 설명한다.
Hereinafter, the present invention will be described in detail.
본 발명의 인삼은 홍삼의 제조에 일반적으로 사용되는 인삼이면 되고, 그 종류가 특별히 제한되지는 않는다. 예컨대, 본 발명의 인삼은 수삼, 백삼, 장뇌삼 등이 될 수 있으나 이에 제한되는 것은 아니다.
The ginseng of the present invention may be ginseng generally used in the production of red ginseng, and the kind thereof is not particularly limited. For example, the ginseng of the present invention may be ginseng, white ginseng, camphor ginseng, and the like, but is not limited thereto.
본 발명의 인삼은 인삼의 뿌리 어느 부분을 사용하여도 무방하다. 예컨대 본 발명의 인삼은 본삼 또는 미삼일 수 있으며, 본삼 및 미삼을 함께 사용할 수도 있다. 또한 본 발명의 실시에 있어서, 본삼 및 미삼을 분리하여 발효시킬 수도 있고, 이들이 결합된 원래 상태대로 발효시킬 수도 있다. 또한 본삼을 발효한 홍삼과 미삼을 발효한 홍삼을 혼합하여 사용할 수도 있다.
The ginseng of the present invention may use any part of the root of ginseng. For example, the ginseng of the present invention may be main ginseng or misam, or may be used together. In addition, in the practice of the present invention, the main and ginseng may be separated and fermented, or may be fermented as it is. You can also use a mixture of red ginseng fermented with red ginseng and fermented red ginseng.
본 발명의 배양은 진세노사이드 함량이 충분히 증진될 수 있는 기간이면 되고, 특별히 배양 기간이 제한되는 것은 아니다. 그러나 발효 효율을 고려할 때, 본 발명의 배양은 2~30일간 수행되는 것이 바람직하다. 이는 발효를 위한 균주가 충분히 증식하기 위하여 2일 이상이 걸리고, 30일 이상 배양 시 진세노사이드 함량의 유의미한 변화가 적어 시간대비 효율이 떨어지기 때문이다. 그러나 이는 발효 효율 및 경제성을 고려한 것이어서 2~30일 외 기간 동안 발효시킨다고 하더라도 본 발명의 범위를 벗어나는 것은 아니다.
The culture of the present invention may be any period in which ginsenoside content can be sufficiently enhanced, and the culture period is not particularly limited. However, in consideration of the fermentation efficiency, the culture of the present invention is preferably carried out for 2 to 30 days. This is because the strain for fermentation takes more than two days to fully grow, and because the significant change in the content of ginsenosides in the culture for more than 30 days is less efficient over time. However, this is in consideration of the fermentation efficiency and economical, even if the fermentation for a period of 2 to 30 days is not outside the scope of the present invention.
본 발명의 표면 배양(surface culture)이란, 고체 배양이라고도 한다.Surface culture of this invention is also called solid culture.
본 발명의 표면 배양은 인삼 또는 홍삼을 마쇄하여 액상화, 분말화한 후 발효를 진행하는 종래 심부배양법과는 달리, 마쇄하지 않고 형체를 유지하는 형태의 인삼의 표면에서 미생물을 배양함으로써, 인삼의 내부보다는 표면이 발효되도록 유도하는 것이다.The surface culture of the present invention, unlike the conventional deep culture method of grinding and liquefying ginseng or red ginseng, and then fermentation, by culturing microorganisms on the surface of the ginseng in the form of maintaining the shape without grinding, the inside of the ginseng Rather, it induces the surface to ferment.
.
.
본 발명의 발효 홍삼은 발효를 거치지 않은 홍삼에 비하여 진세노사이드 함량이 증가된다. 본 발명의 발효 홍삼은 발효홍삼을 거치지 않은 홍삼에 비하여, 특히 Rh2, Rg3, 및 compound K의 함량이 높다.
Fermented red ginseng of the present invention has an increased ginsenoside content as compared to red ginseng that has not undergone fermentation. The fermented red ginseng of the present invention has a higher content of Rh2, Rg3, and compound K than red ginseng without fermented red ginseng.
본 발명의 식품은 건강보조식품, 건강기능식품, 기능성 식품 등이나 이에 제한되는 것은 아니며, 천연식품, 가공식품, 일반적인 식자재 등에 본 발명의 발효 홍삼 또는 발효 인삼을 첨가하는 것도 포함된다.
The food of the present invention is not limited to, but not limited to, health supplements, health functional foods, functional foods, and the like, and includes adding fermented red ginseng or fermented ginseng of the present invention to natural foods, processed foods, and general food materials.
본 발명의 발효 홍삼 또는 발효 인삼을 포함하는 식품 조성물은, 상기 발효 홍삼 또는 발효 인삼을 그대로 첨가하거나 다른 식품 또는 식품 조성물과 함께 사용될 수 있으며, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그의 사용 목적(예방, 개선 또는 치료적 처치)에 따라 적절하게 결정될 수 있다. 일반적으로, 본 발명의 발효 홍삼 또는 발효 인삼은, 식품 또는 음료의 제조 시에 식품 또는 음료의 원료 100 중량부에 대하여 0.1 내지 90 중량부, 바람직하게는 1 내지 60 중량부 첨가될 수 있다.
The food composition comprising the fermented red ginseng or fermented ginseng of the present invention, the fermented red ginseng or fermented ginseng may be added as it is, or may be used with other food or food compositions, and may be suitably used according to a conventional method. The mixed amount of the active ingredient can be appropriately determined depending on the purpose of use (prevention, improvement or therapeutic treatment). Generally, fermented red ginseng or fermented ginseng of the present invention may be added in an amount of 0.1 to 90 parts by weight, preferably 1 to 60 parts by weight, based on 100 parts by weight of the raw material of the food or beverage.
상기 식품의 종류에는 특별한 제한은 없다. 상기 발효 홍삼 또는 발효 인삼을 포함하는 식품 조성물은 정제, 경질 또는 연질 캅셀제, 액제, 현탁제 등과 같은 경구투여용 제제의 형태로 이용될 수 있으며, 이들 제제는 허용 가능한 통상의 담체, 예를 들어 경구투여용 제제의 경우에는 부형제, 결합제, 붕해제, 활택제, 가용화제, 현탁화제, 보존제 또는 증량제 등을 사용하여 조제할 수 있다. There is no particular limitation on the kind of the food. The food composition comprising the fermented red ginseng or fermented ginseng may be used in the form of oral preparations, such as tablets, hard or soft capsules, solutions, suspensions, etc., these preparations are acceptable conventional carriers, such as oral In the case of the preparation for administration, an excipient, a binder, a disintegrant, a lubricating agent, a solubilizer, a suspending agent, a preservative, an extender, etc. can be prepared.
상기 발효 홍삼 또는 발효 인삼을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제, 기타 영양제 등을 들 수 있으나 이들 종류의 식품으로 제한되는 것은 아니다.
Examples of the food to which the fermented red ginseng or fermented ginseng may be added include meat, sausage, bread, chocolate, candy, snacks, confectionary, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, beverages, Teas, drinks, alcoholic beverages and vitamin complexes, and other nutritional supplements, but are not limited to these types of foods.
이하, 본 발명을 다음의 실시예 및 실험예에 의해 보다 상세하게 설명한다. 단, 하기 실시예 및 실험예는 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 실시예 및 실험예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples and experimental examples. However, the following examples and experimental examples are intended to illustrate the contents of the present invention, but the scope of the invention is not limited by the examples and the experimental examples.
<재료 및 방법>≪ Materials and methods >
사용 균주Used strain
본 발명에서 사용한 균주는 락토바실러스 브레비스(Lactobacillus brevis) M2(미생물 기탁번호 KCTC11390BP)로 37℃에서 20-30일간 계대 배양하면서 실험에 사용하였다.
The strain used in the present invention was used in experiments while passaged at 37 ° C. for 20-30 days with Lactobacillus brevis M2 (Microorganism Accession No. KCTC11390BP).
수삼Fresh ginseng
본 발명에서 천연배지로 사용한 수삼은 충북 증평지역에서 2007년도에 수확한 6년근 수삼을 증평 영농조합인삼연구회를 통하여 구입하여 부패 및 품질저하를 방지하기 위하여 -5℃의 냉장실에 보관하면서 사용하였다.
Fresh ginseng used as a natural medium in the present invention was purchased through the 6 year old ginseng harvested in 2007 in the Jeungpyeong area of Chungbuk through the Jeungpyeong farming ginseng research group was used while stored in a cold room at -5 ℃ to prevent decay and quality degradation.
균주의 전배양Preculture of Strains
MRS 배지 (Difco Laboratories, dextrose 20.0 g/L; meat peptone 10.0 g/L; beef extract 10.0 g/L; yeast extract 5.0 g/L; sodium acetate 5.0 g/L; disodium phosphate 2.0 g/L; ammonium citrate 2.0 g/L; tween 80 1.0 g/L; magnesium sulfate 0.1 g/L, manganese sulfate 0.05 g/L)를 사용하여 균주를 37℃에서 48시간 동안 전배양하였다.
MRS medium (Difco Laboratories, dextrose 20.0 g / L; meat peptone 10.0 g / L; beef extract 10.0 g / L; yeast extract 5.0 g / L; sodium acetate 5.0 g / L; disodium phosphate 2.0 g / L; ammonium citrate 2.0 g / L;
시료의 추출 및 수율 측정Sample extraction and yield measurement
수용성 추출물을 얻기 위하여 각각 건조된 시료 100 g에 10배 양의 3차 증류수를 가한 후 40℃ 항온수조에서 3시간씩 교반하면서 3회 반복 추출하였으며, 70% 에탄올 및 70% 메탄올 용매를 수용성 추출물과 동일한 방법으로 추출하였다. 그 후 추출액을 모아 여과지(Whatman No.2, Whatman International Ltd., England)로 여과시켜 여액을 rotatory evaporator (Rotavapor R215, BUCHI, Switzeland)로 감압 농축하여 각각의 용매를 제거시킨 후 freeze dryer (삼원냉열 SF-DSF 12, 부산, 한국)로 동결건조하여 추출 수율을 계산하였다.
To obtain an aqueous extract, 10 times the amount of tertiary distilled water was added to 100 g of the dried sample, and the mixture was extracted three times with stirring for 3 hours in a 40 ° C. constant temperature water bath, and 70% ethanol and 70% methanol solvent were extracted with water-soluble extract. Extracted in the same way. Then, the extracts were collected and filtered through a filter paper (Whatman No. 2, Whatman International Ltd., England), and the filtrate was concentrated under reduced pressure with a rotatory evaporator (Rotavapor R215, BUCHI, Switzeland) to remove each solvent, and then freeze dryer (three-way cold heat). Extraction yield was calculated by lyophilization with SF-
수삼 및 홍삼 가수분해물의 분석Analysis of Hydrolyzed Ginseng and Red Ginseng
폴리페놀함량은 Folin-Denis 법(Dewanto, V., Wu, X., & Liu, R. H. (2002b). Processed sweet corn has higher antioxidant activity. Journal of Agricultural and Food Chemistry, 50, 49594964.)에 준하여 측정하였으며, 총당과 산성당의 함량은 phenol-sulfuric acid법과 Blumenkrantz과 Asboe-Hansen법(Blumenkrantz, N. and Asboe-Hansen, G. (1973) Anal. Biochem., 54, 484)에 의해 측정하였다. Polyphenol content was determined according to the Folin-Denis method (Dewanto, V., Wu, X., & Liu, RH (2002b) .Processed sweet corn has higher antioxidant activity.Journal of Agricultural and Food Chemistry, 50, 49594964.) The total and acid sugar contents were measured by phenol-sulfuric acid method and Blumenkrantz and Asboe-Hansen method (Blumenkrantz, N. and Asboe-Hansen, G. (1973) Anal. Biochem., 54, 484).
진세노사이드의 분석은 HPLC를 사용하여 다음과 같은 방법에 준하여 분석하였다. 각 농축액 1g을 평량하여 70% 에탄올 50 mL을 가하여 80℃ 진탕 배양기에서 2회 추출하고 Whatman #1 paper를 이용하여 여과하였다. 여액은 진공농축기를 이용, 감압 건조하고 50 mL의 증류수를 가하여 용해하였다. 이 용액 1 mL에 디에틸에테르 2 mL을 가하여 혼합한 후, 1500 rpm에서 10분간 원심분리하여 디에틸에테르를 제거하고 여기에 다시 물포화 부탄올을 1.5 mL 가하여 혼합한 다음 부탄올 층을 회수하였다. 3회 재 반복하여 회수한 부탄올층에 증류수 1.5 mL을 가하여 혼합하고 원심분리하여 물층을 제거하였으며 본 조작을 2회 재반복하여 수용성 불순물을 세척하였다. 이렇게 얻어진 부탄올층은 40℃에서 N2 가스를 분사하며 건조하였으며 여기에 메탄올 0.5 mL을 가한 후, 0.45 μm 멤브레인 필터로 여과하여 HPLC 분석용 시료로 사용하였다. HPLC 분석은 Prevail Carbohydrate ES 5μ column(Alltech, USA)이 장착된 HPLC를 이용, ELSD로 분석하였으며 하기 표 1 및 표 2(그레디언트 테이블)에 표시한 바와 같은 조건에서 수행하였다. 한편 진세노사이드 분석 시에는 엠보연구소(대덕, 한국)에서 구입한 14종의 표준물질(compound K, Rh2, Rh1, Rg5, Rk1, Rg2, Rg3, Rg1, Rf, Re, Rd, Rb2, Rc, Rb2)을 이용하여 표준곡선을 작성하고 각 피크 면적비로부터 함량을 계산하였다.
Analysis of ginsenosides was carried out according to the following method using HPLC. 1 g of each concentrate was weighed, and 50 mL of 70% ethanol was added thereto, extracted twice in an 80 ° C shaking incubator, and filtered using
A: Acetonitrile : Water : IPA = 80 : 5 : 15A: Acetonitrile: Water: IPA = 80: 5: 15
B: Acetonitrile : Water : IPA = 67 : 21 : 12
B: Acetonitrile: Water: IPA = 67: 21: 12
<실시예 1 및 실시예 2> <Example 1 and Example 2>
MRS 기본배지에서 배양한 락토바실러스 브레비스 M2(KCTC11390BP) 10%를 6년근 수삼의 본삼(실시예 1) 및 미삼(실시예 2)에 각각 접종하고, 37℃에서 20~30일간 표면배양(고체배양)하여 수삼 표면발효물(고체발효물)을 조제하였다. 그리고 이를 이용하여 홍삼을 제조하였다(도 1).
10% of Lactobacillus brevis M2 (KCTC11390BP) incubated in MRS basal medium was inoculated into main ginseng (Example 1) and rice ginseng (Example 2) of 6-year-old ginseng, respectively, and surface culture (solid culture) at 37 ° C for 20-30 days. The fresh ginseng surface fermentation product (solid fermentation product) was prepared. And red ginseng was prepared using this (FIG. 1).
<비교예 1>≪ Comparative Example 1 &
6년근 수삼을 비교예 1로 사용하였다.
Six-year-old ginseng was used as Comparative Example 1.
<비교예 2>Comparative Example 2
6년근 수삼을 이용하여 홍삼을 제조하였다. 구체적으로는, 수삼을 85~95℃에서 4~5시간 증숙한 후 1차 열풍건조를 하였다. 그리고, 그 후 자연건조를 하여 최종적으로 수분함량이 14% 미만이 되도록 하여 홍삼을 제조하였다.
Red ginseng was prepared using 6 years old ginseng. Specifically, the fresh ginseng was steamed at 85 to 95 ° C. for 4 to 5 hours, followed by primary hot air drying. Then, natural drying was performed to finally prepare red ginseng so that the moisture content was less than 14%.
<비교예 3 및 비교예 4><Comparative Example 3 and Comparative Example 4>
상기 비교예 2에서 제조한 일반 홍삼을 본삼 및 미삼으로 분리하고, 이를 동결 건조한 후 각각 분쇄하였다. 각각의 상기 본삼 분말 및 미삼 분말 5g 씩에 인산염 완충용액(50 mM, pH 5.0) 50 mL을 가하여 현탁한 후, 가압 살균하였다. 가압살균 처리한 홍삼 현탁액에 MRS에서 전배양한 락토바실러스 브레비스 M2(KCTC11390BP)를 2% 접종하여 37℃에서 서서히 교반하면서 5일간 배양하였다. 이때 홍삼 본삼 분말의 발효물을 비교예 3, 홍삼 미삼 분말의 발효물을 비교예 4로 하였다.
The general red ginseng prepared in Comparative Example 2 was separated into main ginseng and rice ginseng, and then lyophilized and ground. 50 mL of phosphate buffer solution (50 mM, pH 5.0) was added to each of 5 g of the main ginseng powder and the ginseng powder, and then suspended by autoclaving. The autoclaved red ginseng suspension was inoculated with 2% of Lactobacillus brevis M2 (KCTC11390BP) pre-cultured in MRS and incubated for 5 days with gentle stirring at 37 ° C. In this case, the fermented product of the red ginseng main ginseng powder was Comparative Example 3, and the fermented product of the red ginseng misam powder was used as Comparative Example 4.
<비교예 5>≪ Comparative Example 5 &
MRS 기본배지에서 배양한 락토바실러스 브레비스 KCTC 3102 10%를 6년근 수삼의 본삼에 접종하고, 37℃에서 20~30일간 표면배양(고체배양)하여 수삼 표면발효물(고체발효물)을 조제하였다. 그리고 이를 이용하여 홍삼을 제조하였다.
10% of Lactobacillus brevis KCTC 3102 cultured in MRS basal medium was inoculated into main ginseng of 6-year-old ginseng, and surface culture (solid culture) at 37 ° C. for 20-30 days to prepare a fresh ginseng surface fermentation product (solid fermentation product). And red ginseng was prepared using this.
<실험예 1> 배양 유무 및 방법에 따른 진세노사이드 함량 변화<
배양 유무 및 그 방법에 따른 진세노사이드 함량 변화를 측정한 결과, 배양 여부에 관계없이 홍삼은 수삼에 비하여 진세노사이드 함량이 증가하는 것으로 확인되었다.
As a result of measuring the ginsenoside content change according to the presence or absence of the cultivation method, it was confirmed that the ginsenoside content was increased in red ginseng regardless of the culture.
그러나 균주 발효를 거친 홍삼의 경우(실시예 1, 실시예 2, 비교예 3 내지 5) 일반적인 방법으로 제조된 홍삼(비교예 2)보다 진세노사이드 함량 증가가 뚜렷하였다. 특히 수삼을 락토바실러스 브레비스 M2(KCTC11390BP)로 표면발효한 후 홍삼으로 제조한 실시예 1 및 실시예 2의 증가량이 유의하게 높았는데, 이들은 Rh2, Rg3 및 compound K 등의 진세노사이드뿐 아니라, 흡수되기 쉬운 형태인 진세노사이드 메타볼라이트의 함량이 전체적으로 상당히 증가하였다(표 3).
However, in the case of the red ginseng after the strain fermentation (Example 1, Example 2, Comparative Examples 3 to 5), the ginsenoside content increase was more pronounced than that of the red ginseng prepared by the general method (Comparative Example 2). In particular, the amount of increase of Example 1 and Example 2 prepared by red ginseng after surface fermentation of ginseng with Lactobacillus brevis M2 (KCTC11390BP) was significantly higher, and these were absorbed as well as ginsenosides such as Rh2, Rg3 and compound K. The content of ginsenoside metabolite, a prone form, increased significantly overall (Table 3).
그러므로 발효 홍삼을 제조 시, 홍삼을 제조한 후 이를 발효시키는 것보다 수삼을 표면발효시키고, 표면발효된 수삼을 증삼하여 홍삼으로 제조하는 것이 진세노사이드 함량이 높은 홍삼의 제조에 유리한 것으로 확인되었다.
Therefore, when preparing fermented red ginseng, it was confirmed that it is advantageous to prepare red ginseng having high ginsenoside content by surface fermenting ginseng and increasing the surface fermented ginseng rather than fermenting it.
파낙스디올(Panaxdiol): Rb1+Rc+Rb2+Rd+Rg3, Panaxdiol: Rb1 + Rc + Rb2 + Rd + Rg3,
파낙스트리올(Panaxtriol): Rg1+Re+Rf+Rh1+Rg2,Panaxtriol: Rg1 + Re + Rf + Rh1 + Rg2,
메타볼라이트(Metabolite)=CK+Rh1+Rg5+Rk1+Rg3+Rg2+Rh2+F2.Metabolite = CK + Rh1 + Rg5 + Rk1 + Rg3 + Rg2 + Rh2 + F2.
.
.
<실험예 2><Experimental Example 2>
상기 실험예 1에서 진세노사이드 함량이 높은 것으로 확인된 실시예 1 및 실시예 2를 7:3으로 혼합하고, 그 진세노사이드 함량을 측정하였다. 이때 대조군으로는 비교예 3 및 비교예 4를 7:3으로 혼합한 혼합물 및 비교예 4를 사용하였다.Example 1 and Example 2 confirmed to have a high ginsenoside content in Experimental Example 1 were mixed at 7: 3, and the ginsenoside content was measured. At this time, a mixture of Comparative Example 3 and Comparative Example 4 7: 3 and Comparative Example 4 was used as a control.
그 결과, 비교예 3 및 4의 혼합물은 총 진세노사이드 함량이 143.1 mg/g으로 표면발효 혼합물(실시예 1 및 2의 혼합물)에 비하여 다소 낮은 함량을 보였으며, 흡수되기 쉬운 진세노사이드 형태인 메타볼라이트함량은 11.4 mg/g으로 거의 유사한 함량을 보였다.
As a result, the mixture of Comparative Examples 3 and 4 had a total ginsenoside content of 143.1 mg / g, which was somewhat lower than the surface fermentation mixture (the mixture of Examples 1 and 2), and was easily absorbed. Phosphorus metabolite content was about 11.4 mg / g, showing a similar content.
실시예 1 및 실시예 2의 혼합물*: 실시예 1 및 실시예 2의 7:3 혼합물Mixture of Example 1 and Example 2 7: 7 Mixture of Example 1 and Example 2
비교예 3 및 비교예 4의 혼합물*: 비교예 3 및 비교예 4의 7:3 혼합물Mixture of Comparative Example 3 and Comparative Example 4: 7: 3 Mixture of Comparative Example 3 and Comparative Example 4
.
.
<실험예 3> 추출수율의 검토Experimental Example 3 Examination of Extraction Yield
실시예 1, 실시예 2 및 비교예 2를 decoction 방법을 이용하여 열수 추출하고, 그 수율을 측정하였다. 구체적으로는 발효홍삼 및 홍삼 100 중량부에 대하여 물을 500 중량부 가하고, 이를 12시간 가열하여 열수 추출물로 조제하고, 그 고형분의 함량으로 수율을 계산하였다(식 1).
Hydrothermal extraction of Example 1, Example 2, and Comparative Example 2 was carried out using the decoction method, and the yield was measured. Specifically, 500 parts by weight of water was added to 100 parts by weight of fermented red ginseng and red ginseng, which was heated for 12 hours to prepare a hot water extract, and the yield was calculated based on the content of the solid content (Equation 1).
<식 1><
수율 = (홍삼 추출물의 고형분 중량/홍삼의 중량)ⅹ100
Yield = (solid weight of red ginseng extract / weight of red ginseng) ⅹ100
그 결과, 본삼 발효물(실시예 1), 미삼 발효물(실시예 2) 및 일반 홈삼(비교예 2)의 수율은 각각 45.7%, 45.5 및 32.3%로 큰 차이를 보이지는 않았다. 그러나 홍삼 발효물(실시예 1 및 2)은 일반 홍삼(비교예 2)의 32.3%에 비해 추출 수율이 높은 것으로 나타났다. 이는 균사체의 발효 과정을 통하여 홍삼의 조직 또는 고분자 구성분이 붕괴되거나 분해되어 동일한 열수추출 조건하에서 추출율이 높게 나타난 것으로 추정되었다.
As a result, the yields of the main ginseng fermented product (Example 1), micro ginseng fermented product (Example 2) and general home ginseng (Comparative Example 2) did not show a big difference, respectively, at 45.7%, 45.5 and 32.3%. However, red ginseng fermentation products (Examples 1 and 2) were found to have a higher extraction yield than 32.3% of general red ginseng (Comparative Example 2). It was estimated that the red ginseng's tissues or polymer components were disintegrated or decomposed through the fermentation process of mycelium, resulting in high extraction rate under the same hydrothermal extraction conditions.
<실험예 4> 수삼의 표면 발효 중 성분 변화Experimental Example 4 Changes in Components during Surface Fermentation of Fresh Ginseng
<4-1>본삼의 표면 발효 중 성분 변화<4-1> Changes in Components of Surface Ginseng during Fermentation
MRS 기본배지에서 배양한 락토바실러스 브레비스 M2(KCTC11390BP) 10%를 6년근 수삼의 본삼에 각각 접종하고, 37℃에서 20~30일간 표면배양(고체배양)하면서, 발효 시간에 따른 성분 변화를 측정하였다.
10% of Lactobacillus brevis M2 (KCTC11390BP) incubated in MRS basal medium was inoculated into the main ginseng of 6-year-old ginseng, and surface changes (solid culture) were performed at 37 ° C for 20 to 30 days, and the changes of the components according to the fermentation time were measured. .
그 결과 총 당(total sugar)의 함량은 발효 시간이 경과할수록 감소하는 경향을 보였으며, 산성당인 uronic acid는 6-9일째 가장 높은 함량을 보였다. 반면 폴리페놀의 함량변화는 발효 과정중에 다소 증가하였으나 발효시간에 따른 경향의 변화가 뚜렸하지 않았다. 표면발효시 발효에 관여하는 균수는 발효시간이 증가할수록 증가하는 경향을 보였으며, 발효 6일째 이후 균수의 증가가 완만하게 증가를 하였다(도 2).
As a result, the total sugar content tended to decrease with the fermentation time and the acidic sugar uronic acid showed the highest content in 6-9 days. On the other hand, the content of polyphenols increased slightly during the fermentation process, but the change of the tendency with fermentation time was not significant. The number of bacteria involved in fermentation during surface fermentation tended to increase as the fermentation time increased, and after 6 days of fermentation, the number of bacteria increased slowly (Fig. 2).
<4-2> 미삼의 표면 발효 중 성분 변화<4-2> Changes in Components during Surface Fermentation of Rice Ginseng
MRS 기본배지에서 배양한 락토바실러스 브레비스 M2(KCTC11390BP) 10%를 6년근 수삼의 미삼에 각각 접종하고, 37℃에서 20~30일간 표면배양(고체배양)하면서, 발효 시간에 따른 성분 변화를 측정하였다.
10% of Lactobacillus brevis M2 (KCTC11390BP) incubated in MRS basal medium was inoculated into the ginseng of 6-year-old ginseng, and surface changes (solid culture) were performed at 37 ° C for 20 to 30 days, and the changes of the components according to the fermentation time were measured. .
그 결과, 총 당(total sugar)의 함량은 9일 발효 시까지 발효 시간이 경과할수록 증가를 하다가 이후에 감소하는 경향을 보였으며, 산성당인 uronic acid 함량 변화 역시 총 당의 함량 변화와 유사한 경향을 보였다. 폴리페놀 함량변화는 발효 과정 중에 다소 증가하였으며, 15일째에는 다소 감소하였다. 표면 발효시 발효에 관여하는 균수는 3일 발효시 급격히 균수가 증가를 하다가 이후 완만하게 감소하는 경향을 보였으나 발효 시간 간의 유의적인 차이는 없었다. 그러나 발효 15일째에는 균수가 감소하였다. 미삼의 경우 본삼에 비해 표면적인 넓기 때문에 발효가 빨리 진행되는 경향을 보였으며, 이는 성분의 변화에 큰 영향을 미치는 것으로 판단된다.
As a result, the total sugar content increased with the fermentation time until the 9th fermentation and then decreased. The uronic acid content of acidic sugars also showed a similar tendency to the total sugar content. . Changes in polyphenol content increased slightly during fermentation and decreased slightly at 15 days. The number of bacteria involved in fermentation during surface fermentation increased rapidly after 3 days fermentation and then gradually decreased, but there was no significant difference between fermentation times. However, at 15 days of fermentation, the number of bacteria decreased. In the case of rice ginseng, fermentation tended to be faster because of its surface area wider than that of main ginseng.
Claims (9)
상기 인삼에 락토바실러스 브레비스 M2(Lactobacillus brevis) M2(기탁번호 KCTC11390BP)를 접종하여, 상기 인삼의 표면에서 고체배양시키는 단계;및
상기 고체배양된 인삼을 증삼하여 홍삼으로 제조하는 단계를 포함하는, Rg3 및 컴파운드 K의 함량이 증가된 발효 홍삼의 제조 방법.
Preparing ginseng;
Inoculating the ginseng with Lactobacillus brevis M2 (Accession No. KCTC11390BP) to solid culture on the surface of the ginseng; and
Method of producing a fermented red ginseng with increased content of Rg3 and Compound K, comprising the step of producing red ginseng by increasing the solid cultured ginseng.
상기 인삼은 본삼 및 미삼으로 구성된 군으로부터 선택되는 하나 이상인 것을 특징으로 하는 제조 방법.
The method of claim 1,
The ginseng is a production method, characterized in that at least one selected from the group consisting of main ginseng and misam.
상기 배양은 2 ~ 30일간 수행되는 것을 특징으로 하는 제조 방법.
The method of claim 1,
The culture method is characterized in that it is carried out for 2 to 30 days.
상기 발효 홍삼은 발효를 거치지 않은 홍삼에 비하여 진세노사이드 함량이 증가된 것을 특징으로 하는 제조 방법.
The method of claim 1,
The fermented red ginseng is characterized in that the ginsenoside content is increased compared to the red ginseng not fermented.
상기 발효 홍삼은 발효를 거치지 않은 홍삼에 비하여, Rh2, Rg3 및 컴파운드 K의 함량이 증가된 것을 특징으로 하는 제조 방법.
The method of claim 1,
The fermented red ginseng is characterized in that the content of Rh2, Rg3 and compound K is increased compared to the red ginseng not fermented.
Fermented red ginseng prepared by the method of any one of claims 1 to 5.
Food composition comprising a fermented red ginseng prepared by the method of any one of claims 1 to 5 as an active ingredient.
본삼으로부터 제조한 발효 홍삼 및 미삼으로부터 제조한 발효 홍삼을 포함하는 것을 특징으로 하는 식품 조성물.
8. The method of claim 7,
A food composition comprising fermented red ginseng prepared from main ginseng and fermented red ginseng prepared from misam.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110083090A KR101328179B1 (en) | 2011-08-19 | 2011-08-19 | Preparation method of fermented red ginseng having high ginsenoside contents using surface culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110083090A KR101328179B1 (en) | 2011-08-19 | 2011-08-19 | Preparation method of fermented red ginseng having high ginsenoside contents using surface culture |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130020446A KR20130020446A (en) | 2013-02-27 |
KR101328179B1 true KR101328179B1 (en) | 2013-11-13 |
Family
ID=47898388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110083090A KR101328179B1 (en) | 2011-08-19 | 2011-08-19 | Preparation method of fermented red ginseng having high ginsenoside contents using surface culture |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101328179B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102001740B1 (en) * | 2017-12-21 | 2019-07-18 | 경남과학기술대학교 산학협력단 | Liquid composition for preventing and relieving hangover with high content of ginsenoside F2, R3 and compound K comprising and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060023654A (en) * | 2004-09-10 | 2006-03-15 | 이인경 | Method for preparing of red-koji ginseng |
KR100866504B1 (en) * | 2008-09-23 | 2008-11-11 | 주식회사 비티씨 | Microorganisms for fermentation of red ginseng and food composition containing fermented red ginseng |
-
2011
- 2011-08-19 KR KR1020110083090A patent/KR101328179B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060023654A (en) * | 2004-09-10 | 2006-03-15 | 이인경 | Method for preparing of red-koji ginseng |
KR100866504B1 (en) * | 2008-09-23 | 2008-11-11 | 주식회사 비티씨 | Microorganisms for fermentation of red ginseng and food composition containing fermented red ginseng |
Also Published As
Publication number | Publication date |
---|---|
KR20130020446A (en) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101753077B1 (en) | A method for preparing fermented ginseng extract and compositions comprising thereof | |
KR101164529B1 (en) | Ginseng fermentation system for Ginsenoside increase | |
KR101370386B1 (en) | Preparation method of fermented red ginseng using effective micro-organisms | |
KR101486648B1 (en) | Fermented Sparassis crispa and method for preparing the same | |
KR20170061959A (en) | Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption | |
KR101823585B1 (en) | Methods for preparing fermented ginseng extracts | |
KR20160013731A (en) | Preparation method of ginseng fermentation product enhanced ginsenoside Rh2 and Rg3 content | |
KR20190079514A (en) | Cosmetic composition for skin moisturizing comprising fermented aloe as effective component | |
KR20220136107A (en) | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same | |
KR20100074382A (en) | Fermented drinks of ginseng and preparation method thereof | |
KR101690779B1 (en) | A method for manufacturing fermented composition comprising red gingseng and rubus coreanus and the fermented composition by the method | |
KR101341263B1 (en) | Method for manufacturing fermented turmeric using a probiotic strain, Lactobacills johnsonii IDCC 9203 | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
KR100848686B1 (en) | A FERMENTED GINSENG COMPOSITION STRENGTHENED SIMULTANEOUSLY WITH γ-AMINOBUTYRIC ACID AND BIOCONVERSION SAPONIN BY LACTIC ACID BACTERIA | |
KR101328179B1 (en) | Preparation method of fermented red ginseng having high ginsenoside contents using surface culture | |
KR102151011B1 (en) | Composition for preventing, improving or treating liver disease comprising fermented liquor of aged sprout ginseng extract as effective component | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
KR20200078171A (en) | The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria | |
KR20080029989A (en) | Lipase inhibitor including processed ginseng, functional food and medical composition including the lipase inhibitor | |
KR102132537B1 (en) | Platycodon grandiflorum Liquid composition for stick-type container having increased ginsenosides of human body absorption type, and preparation method thereof | |
KR101794637B1 (en) | Fermentation Process of a Garlic Using New Strain of Bacillus subtilis | |
KR102042151B1 (en) | A composition as a prebiotic for improving intestinal microflora containing extract from pepper leaves | |
KR20120019311A (en) | Composition for immunostimulation which comprises polysaccharide from fermented ginseng with phellinus linteus to enhance the immune function | |
KR101755118B1 (en) | Manufacture of extract solution and capsules of ginseng-allium hookeri compound fermentation using microorganism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20161012 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20171016 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20181105 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20191104 Year of fee payment: 7 |